Atlas Trials

Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease

Clinical trial NCT02188160 · COMPLETED

Trial details

NCT number
NCT02188160
Sponsor
Kala Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Dry Eye SyndromesKeratoconjunctivitis Sicca
Start date
2014-06-01
Primary completion
2015-01-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.